This page is limited to our registered members

Get access to exclusive dermatological services to increase your professionnal knowledge: +500 pathology visuals, clinical cases, expert videos
Benefit from valuable features: audio listening, materials to be shared with your patients
Stay informed about the upcoming events and webinars, latest scientific publications and product innovations

Already have an account? login now

Updates on Dermatology: Rosacea

Summary of the Bioderma Symposium held during the European Academy of Dermatology and Venerology in Paris in September 2025 about: "Management of Rosacea: for a better patient’s outcome", with Prof. Bernard Cribier, Prof. Brigitte Dreno, Prof. Mark Kaufmann and Dr. Fauverghe (Naos).

Related topics

Dr. Stéphane Fauverghe

General practitioner , France

Naos International Medical Director

EADV Symposium, Paris – Rosacea Management for a Better Patient Outcome

Rosacea is a complex, multifactorial disease that extends far beyond the skin, impacting self-esteem, social interactions, and overall quality of life. As our understanding of rosacea deepens, so does our commitment to improving patient outcomes through science and empathy.

This special issue brings together four expert perspectives from the EADV symposium in Paris, each offering a unique lens on

rosacea management:

Prof. Bernard Cribier explores the evolving pathophysiology of rosacea, highlighting the roles of immune and neurovascular dysregulation, and the promise of targeted therapies.
Prof. Brigitte Dréno examines the interplay between the skin and gut microbiome, challenging old assumptions and pointing to the nuanced effects of microbial communities and the potential of probiotics.
Prof. Mark D. Kaufmann reviews advances in therapeutic strategies, from sub-antimicrobial antibiotics to innovative topical agents, emphasising the importance of anti-inflammatory approaches and maintenance therapy.
To conclude, I present our ecobiological approach, focusing on both the physical and psychological well-being of patients. Solutions like ROSACTIV™ 2.0 technology included in the SENSIBIO AR+ products, rooted in ecobiology, aim to address the underlying mechanisms of rosacea while respecting the skin’s natural balance.

What unites these contributions is a shared vision: to move beyond symptom control and address the root causes of rosacea, integrating cutting-edge research with holistic, patient-centered ca

re. The future of rosacea management lies in personalised, multidisciplinarystrategies that honour the complexity of the disease and the individuality of each patient.

I am proud to introduce this collection, which reflects our collective dedication to advancing knowledge and compassion in rosacea care.

This page is limited to our registered members

Updates on Dermatology: Rosacea

Edito

Review in PDF